Announced Thu, 9 Jul · 11:41 IST
SEBI Regulation 74(5) compliance certificate for Q1FY27
Compliance View source PDF
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹865.60
prior close
₹874.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.3-0.4+0.4-1.2-2.1+0.5-1.4-1.9-3.4————
Up moveDown movePending
AI summary
Supriya Lifescience has submitted a quarterly compliance certificate from its registrar MUFG Intime India, confirming that securities received for dematerialisation during the quarter ended June 30, 2026 were processed. Physical share certificates were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's register of members. This is a routine SEBI-mandated filing required from listed companies every quarter.
Likely market impact
Routine regulatory filing. No material effect on the company, business, or shareholders.